Zepp Health Corporation (ZEPP)

For informational purposes only. Not financial advice.

Zepp Health Corporation (ZEPP) is a publicly traded company trading at $29.60 with a market cap of 117984238. It holds a moderate AI score of 51/100 based on fundamental, technical, and sentiment analysis.

Zepp Health Corporation develops, manufactures, and sells smart wearable devices in China. The company operates through Xiaomi Wearable Products and Self-Branded Products segments, offering products under the Xiaomi and Amazfit brands.

51/100 AI Score MCap 118M Vol 87K

Company Overview

CEOWang Huang
Employees765
HeadquartersHefei, CN
IPO Year2018

Zepp Health Corporation (ZEPP) pioneers accessible health and fitness tracking with its innovative smart wearables, leveraging its strong Xiaomi partnership and expanding Amazfit brand to capture the growing demand for personal health monitoring solutions in the Chinese market and beyond.

Investment Thesis

Investing in Zepp Health Corporation presents a compelling opportunity due to the growing demand for wearable technology and the company's established presence in the Chinese market. While the company currently has a negative P/E ratio of -1.02 and a negative profit margin of -28.5%, its gross margin of 37.2% suggests potential for improved profitability. Key value drivers include the expansion of the Amazfit brand, continued partnership with Xiaomi, and innovation in health monitoring features. Growth catalysts include increasing adoption of wearable technology for health management and expansion into international markets. Investors should monitor the company's ability to improve profitability and manage its operating expenses effectively.

Key Highlights

  • Market Cap of $0.07B reflects its current valuation in the competitive consumer electronics market.
  • Gross Margin of 37.2% indicates the profitability of its products before operating expenses.
  • Operates through two segments: Xiaomi Wearable Products and Self-Branded Products and Others, diversifying its revenue streams.
  • Offers products under the Xiaomi and Amazfit brands, catering to different market segments.
  • Beta of 1.47 suggests higher volatility compared to the market, indicating potential for significant price swings.

Competitors

Strengths

  • Strong partnership with Xiaomi.
  • Established brand recognition in China.
  • Diverse product portfolio.
  • Proprietary technology in health monitoring.

Weaknesses

  • Negative profit margin.
  • High reliance on Xiaomi partnership.
  • Intense competition in the wearable market.
  • Limited brand recognition outside of China.

Catalysts

  • Upcoming: Launch of new Amazfit products with advanced health monitoring features in Q2 2026.
  • Ongoing: Expansion of distribution channels in international markets throughout 2026.
  • Ongoing: Continued innovation in health data analytics and personalized insights.

Risks

  • Potential: Intensifying competition from larger players with greater resources.
  • Potential: Economic slowdown in China impacting consumer spending.
  • Ongoing: Reliance on Xiaomi partnership could be a risk if the partnership weakens.
  • Potential: Supply chain disruptions affecting manufacturing and distribution.
  • Ongoing: Negative profit margins may continue if cost efficiencies are not realized.

Growth Opportunities

  • Expansion of the Amazfit Brand: Zepp Health can drive growth by further developing and marketing its Amazfit brand globally. This includes introducing new product categories, enhancing brand awareness through marketing campaigns, and expanding distribution channels. The global smartwatch market is projected to reach $70 billion by 2028, providing a substantial market opportunity for Amazfit products.
  • Strengthening the Xiaomi Partnership: Zepp Health's partnership with Xiaomi provides a stable revenue stream and access to a large customer base. By continuing to innovate and develop new wearable devices for Xiaomi, Zepp Health can maintain its position as a key supplier and benefit from Xiaomi's growth in the global market. This ongoing collaboration is crucial for sustained revenue generation.
  • Focus on Health Monitoring Innovation: Zepp Health can differentiate itself by investing in research and development to enhance its health monitoring capabilities. This includes developing new sensors, algorithms, and software features that provide users with more accurate and actionable health insights. The market for health monitoring devices is growing rapidly, driven by increasing consumer interest in preventative healthcare.
  • Geographic Expansion Beyond China: While Zepp Health has a strong presence in China, expanding into new geographic markets presents a significant growth opportunity. This includes targeting emerging markets with affordable wearable devices and developed markets with premium products. International expansion requires adapting products and marketing strategies to local market conditions.
  • Development of Value-Added Services: Zepp Health can generate recurring revenue by offering value-added services to its users. This includes premium subscriptions for advanced health analytics, personalized coaching programs, and integration with third-party health and fitness platforms. The market for digital health services is growing rapidly, providing a significant opportunity for Zepp Health to diversify its revenue streams.

Opportunities

  • Expansion into new geographic markets.
  • Development of value-added services.
  • Innovation in health monitoring technology.
  • Partnerships with other technology companies.

Threats

  • Intensifying competition from established players.
  • Changes in consumer preferences.
  • Economic slowdown in key markets.
  • Supply chain disruptions.

Competitive Advantages

  • Established partnership with Xiaomi provides a stable revenue stream.
  • Strong brand recognition in the Chinese market.
  • Proprietary technology and algorithms for health monitoring.
  • Economies of scale in manufacturing wearable devices.

About

Zepp Health Corporation, formerly known as Huami Corporation, was founded in 2013 and is headquartered in Hefei, China. The company has rapidly evolved into a key player in the smart wearable technology market. Zepp Health develops, manufactures, and sells a diverse range of smart wearable devices, including smart bands, watches, and scales. These products are marketed under both the Xiaomi and Amazfit brands. The company operates through two primary segments: Xiaomi Wearable Products, which focuses on devices manufactured for Xiaomi, and Self-Branded Products and Others, encompassing the Amazfit line and other ventures. Beyond wearables, Zepp Health also offers smart hearable products, home treadmills, sportswear, home appliances, and smartwatch accessories. Zepp Health provides users with comprehensive charts and graphs through its Zepp Life and Zepp mobile apps, enabling detailed analysis of activity and biometric data. This data-driven approach underscores the company's commitment to empowering users with actionable insights into their health and fitness.

What They Do

  • Develops smart wearable technological devices.
  • Manufactures smart bands, watches, and scales.
  • Sells products under the Xiaomi and Amazfit brands.
  • Offers smart hearable products.
  • Provides home treadmills and sportswear.
  • Sells home appliances and smartwatch accessories.
  • Offers Zepp Life and Zepp mobile apps for data analysis.

Business Model

  • Sells smart wearable devices to consumers.
  • Generates revenue through the Xiaomi Wearable Products segment.
  • Generates revenue through the Self-Branded Products and Others segment.
  • Offers mobile applications for data analysis and user engagement.

Industry Context

Zepp Health operates in the rapidly expanding consumer electronics industry, specifically within the smart wearable technology segment. The market is driven by increasing consumer awareness of health and fitness, coupled with technological advancements in sensors and data analytics. Competition is intense, with major players like Apple and Samsung, as well as specialized fitness brands. Zepp Health differentiates itself through its partnership with Xiaomi and its focus on providing affordable yet feature-rich wearable devices. The global wearables market is projected to continue growing, presenting significant opportunities for Zepp Health to expand its market share.

Key Customers

  • Consumers interested in health and fitness tracking.
  • Xiaomi customers purchasing wearable devices.
  • Users of the Amazfit brand.
  • Individuals seeking smart accessories and home appliances.
AI Confidence: 72% Updated: 2/8/2026

Financials

Recent Quarterly Results

Quarter Revenue Net Income EPS
Q3 2025 $540M -$12M $-0.73
Q2 2025 $427M -$56M $-3.51
Q1 2025 $280M -$143M $-8.95
Q4 2024 $433M -$269M $-16.60

Source: Company filings

Chart & Info

Price Chart

Zepp Health Corporation (ZEPP) stock price: $29.60 (+1.57, +5.60%)

Why Bull

  • Recent insider buying suggests confidence in the company's future, indicating that leadership believes in upcoming growth.
  • Community sentiment has leaned positive, with many discussions highlighting the potential for expansion in health tech markets.
  • Innovations in wearable technology have sparked interest, positioning Zepp Health as a key player in a growing industry.
  • Positive reviews and user feedback on new product releases have bolstered brand loyalty and consumer interest.

Why Bear

  • Concerns about competition in the wearable tech sector have surfaced, with rivals gaining traction and market share.
  • Recent earnings calls reflected challenges in supply chain management, raising questions about the company's operational efficiency.
  • Some community members express skepticism over the sustainability of growth, pointing to market saturation as a potential risk.
  • Market perception remains cautious, with some analysts questioning the long-term viability of Zepp's business model in a rapidly evolving landscape.

Latest News

Technical Analysis

bearish Trend
RSI(14)
33.9
MACD
--
Volume
86,234

Rationale

AI-generated technical analysis for ZEPP including trend direction, momentum, and pattern recognition.

What to Watch

Key support and resistance levels, volume signals, and upcoming events.

Risk Management

Position sizing, stop-loss levels, and risk-reward assessment.

Community

Discussion

Share your analysis and discuss Zepp Health Corporation (ZEPP) with other investors. Log in to post.

Sentiment

Community sentiment and discussion activity for ZEPP.

Make a Prediction

Set your price target for Zepp Health Corporation (ZEPP), choose a timeframe, and track your prediction accuracy.

Current price: $29.60

Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for ZEPP.

Price Targets

Low
$12.00
Consensus
$12.00
High
$12.00

Median: $12.00 (-59.5% from current price)

Insider Flow (30d)

No insider trades in the last 30 days.

MoonshotScore

51/100

Score Factors

  • Revenue Growth 2/100

    Revenue declined -46.6% YoY, signaling shrinking demand or market headwinds.

  • Gross Margin 6/100

    Gross margin of 37.2% is acceptable but leaves limited room for R&D and marketing investment.

  • Operating Leverage 4/100

    Limited operating leverage due to slower revenue growth, keeping profit scaling constrained.

  • Cash Runway 8/100

    Strong cash reserves of $808M provide a solid financial cushion for growth investments and market downturns.

  • R&D Intensity 10/100

    Investing 25.3% of revenue in R&D signals heavy commitment to innovation and future product pipeline.

  • Insider Activity 6/100

    No significant insider buying or selling recently, which is neutral for the stock outlook.

  • Short Interest 10/100

    Daily turnover of 0.89% indicates healthy liquidity with smooth entry/exit for investors.

  • Price Momentum 0/100

    No bullish technical signals detected. The stock lacks upward price momentum currently.

  • News Sentiment 5/100

    No sentiment data available

What does this score mean?

The MoonshotScore rates ZEPP's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Frequently Asked Questions

What does Zepp Health Corporation do?

Zepp Health Corporation designs, develops, manufactures, and sells smart wearable devices, primarily under the Xiaomi and Amazfit brands. The company operates through two segments: Xiaomi Wearable Products and Self-Branded Products and Others. Zepp Health provides a range of products including smart bands, watches, scales, and hearable products, along with related accessories. Its mobile applications, Zepp Life and Zepp, offer users comprehensive health and fitness data analysis, reinforcing its position in the consumer electronics and health technology market.

Is ZEPP stock a good buy?

ZEPP stock presents a speculative investment opportunity. While the company has a negative P/E ratio of -1.02 and a negative profit margin of -28.5%, its gross margin of 37.2% suggests potential for future profitability. Growth catalysts include expanding the Amazfit brand and innovating in health monitoring. Investors should carefully consider the risks, including intense competition and reliance on the Xiaomi partnership, before investing. Monitoring the company's ability to improve profitability and expand its market share is crucial.

What are the main risks for ZEPP?

Zepp Health faces several key risks. Intense competition in the wearable technology market from established players like Apple and Samsung could erode market share. Economic slowdowns in China and other key markets could reduce consumer spending on discretionary items like wearables. The company's reliance on its partnership with Xiaomi creates a concentration risk. Supply chain disruptions could impact manufacturing and distribution. Finally, the company's current negative profit margins pose a risk to its long-term financial sustainability.

Is ZEPP a good stock to buy?

Whether ZEPP is a suitable investment depends on your goals, risk tolerance, and time horizon. Evaluate Zepp Health Corporation's revenue growth, profit margins, debt levels, and valuation relative to peers. This is not financial advice.

What is the ZEPP MoonshotScore?

The MoonshotScore rates ZEPP from 0 to 100 across growth potential, financial health, market momentum, and risk factors. Scores above 70 suggest strong potential, 50-70 moderate, and below 50 warrants caution. It is recalculated daily using the latest market data. This score is informational only.

How often is ZEPP data updated?

ZEPP prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What do analysts say about ZEPP?

Analyst coverage for ZEPP includes consensus ratings (buy, hold, sell), 12-month price targets, and earnings estimates from major research firms. Key data points: consensus target price, number of covering analysts, recent upgrades or downgrades, and earnings beat/miss history. See the Analyst Consensus section on this page.

What are the risks of investing in ZEPP?

Risk categories for ZEPP include market risk, company-specific risk (management, competition), financial risk (debt, cash burn), and macroeconomic risk (rates, inflation). Beta above 1.0 indicates higher volatility than the S&P 500. Review the Risk Factors section on this page for details. All investments carry risk of loss.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Data provided for informational purposes only.

AI Analysis Notes
  • Financial data is based on the most recent available information.
  • Market projections are subject to change.
  • Competitive landscape is dynamic and may evolve rapidly.
Data Sources
profilefundamentalsexistingCopy